| Literature DB >> 29296921 |
Ana Raykova1, Paolo Carrega2, Frank M Lehmann3,4, Robert Ivanek5,6, Vanessa Landtwing1, Isaak Quast7, Jan D Lünemann8, Daniela Finke3,4, Guido Ferlazzo2,9,10, Obinna Chijioke1, Christian Münz1.
Abstract
Type 3 innate lymphoid cells (ILC3s) fulfill protective functions at mucosal surfaces via cytokine production. Although their plasticity to become ILC1s, the innate counterparts of type 1 helper T cells, has been described previously, we report that they can differentiate into cytotoxic lymphocytes with many characteristics of early differentiated natural killer (NK) cells. This transition is promoted by the proinflammatory cytokines interleukin 12 (IL-12) and IL-15, and correlates with expression of the master transcription factor of cytotoxicity, eomesodermin (Eomes). As revealed by transcriptome analysis and flow cytometric profiling, differentiated ILC3s express CD94, NKG2A, NKG2C, CD56, and CD16 among other NK-cell receptors, and possess all components of the cytotoxic machinery. These characteristics allow them to recognize and kill leukemic cells with perforin and granzymes. Therefore, ILC3s can be harnessed for cytotoxic responses via differentiation under the influence of proinflammatory cytokines.Entities:
Year: 2017 PMID: 29296921 PMCID: PMC5745129 DOI: 10.1182/bloodadvances.2017008839
Source DB: PubMed Journal: Blood Adv ISSN: 2473-9529